Bosulif (bosutinib), a drug used to treat leukemia, is now available for prescription at general hospitals.

According to the industry sources, Pfizer Korea’s Bosulif, a drug used to treat Chronic Myelogenous Leukemia (CML), has passed the drug committee (DC) of general hospitals, including Seoul National University Hospital, Seoul St. Mary's Hospital, and Pusan National University Hospital. It is also preparing for the landing at other tertiary general hospitals, including Samsung Seoul Hospital and Seoul Asan Hospital.

After securing a reimbursement listing in January, Bosulif has been expanding its prescription domain. However, patients are complaining about the reimbursemen